SCHEMBL13126361

SCHEMBL13126361

Cc1sc(NC(=O)Cc2ccc3ccccc3c2)c(C(N)=O)c1C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 3/20 0.65
MAPT P10636 4/20 0.56
ALDH1A1 P00352 9/20 0.54
AIP O00170 1/20 0.54
SGTA O43765 1/20 0.54
TOMM70 O94826 1/20 0.54
STIP1 P31948 1/20 0.54
PPP5C P53041 1/20 0.54
FKBP4 Q02790 1/20 0.54
PPID Q08752 1/20 0.54
FKBP5 Q13451 1/20 0.54
FKBP8 Q14318 1/20 0.54
TOMM34 Q15785 1/20 0.54
DNAJC7 Q99615 1/20 0.54
AIPL1 Q9NZN9 1/20 0.54
STUB1 Q9UNE7 1/20 0.54
RAB9A P51151 2/20 0.53
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.53
GAA P10253 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18180597 0.83 L3MBTL1 (0.66) MAPK8MAPTALDH1A1AIPSGTA
SCHEMBL31060214 0.79 MAPK8 (1.00) MAPK8MAPTALDH1A1AIPSGTA
SCHEMBL13126363 0.79 MAPK8 (1.00) MAPK8MAPTALDH1A1AIPSGTA
SCHEMBL7676531 0.79 MAPK8 (0.63) MAPK8MAPTALDH1A1AIPSGTA
SCHEMBL13781600 0.78 HCAR2 (0.56) MAPK8MAPTALDH1A1MEN1KMT2A
SCHEMBL18177310 0.77 MAPT (0.61) MAPK8MAPTALDH1A1AIPSGTA
SCHEMBL6999034 0.72 MAPK8 (0.68) MAPK8MAPTALDH1A1AIPSGTA
SCHEMBL7670751 0.71 MAPK8 (0.67) MAPK8MAPTALDH1A1AIPSGTA
SCHEMBL7886663 0.71 MAPK8 (0.55) MAPK8MAPTALDH1A1AIPSGTA
SCHEMBL20852895 0.71 ADORA1 (0.55) MAPK8MAPTALDH1A1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240720-A1 ALLOSTERIC JNK INHIBITORS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-09-23 US disclosed
US-20100240720-A1 ALLOSTERIC JNK INHIBITORS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2010-09-23 US disclosed
WO-2010108115-A1 ALLOSTERIC JNK INHIBITORS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240720-A1 ALLOSTERIC JNK INHIBITORS MCL1, MAPKAPK2, MAP3K6 MAPK8 21/4885MAPT 588/4885ALDH1A1 4814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.